Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Evaluation of the NOD/SCID xenograft model for glucocorticoid-regulated gene expression in childhood B-cell precursor acute lymphoblastic leukemia.

Bhadri VA, Cowley MJ, Kaplan W, Trahair TN, Lock RB.

BMC Genomics. 2011 Nov 17;12:565. doi: 10.1186/1471-2164-12-565.

2.
3.

Good engraftment of B-cell precursor ALL in NOD-SCID mice.

Baersch G, Möllers T, Hötte A, Dockhorn-Dworniczak B, Rübe C, Ritter J, Jürgens H, Vormoor J.

Klin Padiatr. 1997 Jul-Aug;209(4):178-85.

PMID:
9293448
4.

Preclinical analysis of the γ-secretase inhibitor PF-03084014 in combination with glucocorticoids in T-cell acute lymphoblastic leukemia.

Samon JB, Castillo-Martin M, Hadler M, Ambesi-Impiobato A, Paietta E, Racevskis J, Wiernik PH, Rowe JM, Jakubczak J, Randolph S, Cordon-Cardo C, Ferrando AA.

Mol Cancer Ther. 2012 Jul;11(7):1565-75. doi: 10.1158/1535-7163.MCT-11-0938. Epub 2012 Apr 13.

5.

Opposing regulation of BIM and BCL2 controls glucocorticoid-induced apoptosis of pediatric acute lymphoblastic leukemia cells.

Jing D, Bhadri VA, Beck D, Thoms JA, Yakob NA, Wong JW, Knezevic K, Pimanda JE, Lock RB.

Blood. 2015 Jan 8;125(2):273-83. doi: 10.1182/blood-2014-05-576470. Epub 2014 Oct 21.

6.
7.

Establishment of reproducible xenotransplantation model of T cell acute lymphoblastic leukemia in NOD/SCID mice.

Wang D, Wang N, Zhang Y, Ma S, Geng Z, Zhou P, Zhou J, Huang L.

J Huazhong Univ Sci Technolog Med Sci. 2012 Aug;32(4):511-6. doi: 10.1007/s11596-012-0088-5. Epub 2012 Aug 11.

PMID:
22886962
8.

Targeting of the deubiquitinase USP9X attenuates B-cell acute lymphoblastic leukemia cell survival and overcomes glucocorticoid resistance.

Zhou M, Wang T, Lai H, Zhao X, Yu Q, Zhou J, Yang Y.

Biochem Biophys Res Commun. 2015 Apr 3;459(2):333-9. doi: 10.1016/j.bbrc.2015.02.115. Epub 2015 Feb 28.

PMID:
25735983
9.

High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias.

Morisot S, Wayne AS, Bohana-Kashtan O, Kaplan IM, Gocke CD, Hildreth R, Stetler-Stevenson M, Walker RL, Davis S, Meltzer PS, Wheelan SJ, Brown P, Jones RJ, Shultz LD, Civin CI.

Leukemia. 2010 Nov;24(11):1859-66. doi: 10.1038/leu.2010.184. Epub 2010 Aug 26.

10.

Divergent mechanisms of glucocorticoid resistance in experimental models of pediatric acute lymphoblastic leukemia.

Bachmann PS, Gorman R, Papa RA, Bardell JE, Ford J, Kees UR, Marshall GM, Lock RB.

Cancer Res. 2007 May 1;67(9):4482-90.

11.

Attenuated measles virus controls pediatric acute B-lineage lymphoblastic leukemia in NOD/SCID mice.

Lühl NC, Zirngibl F, Dorneburg C, Wei J, Dahlhaus M, Barth TF, Meyer LH, Queudeville M, Eckhoff S, Debatin KM, Beltinger C.

Haematologica. 2014 Jun;99(6):1050-61. doi: 10.3324/haematol.2013.087205. Epub 2014 Apr 3.

12.

RAC2, AEP, and ICAM1 expression are associated with CNS disease in a mouse model of pre-B childhood acute lymphoblastic leukemia.

Holland M, Castro FV, Alexander S, Smith D, Liu J, Walker M, Bitton D, Mulryan K, Ashton G, Blaylock M, Bagley S, Connolly Y, Bridgeman J, Miller C, Krishnan S, Dempsey C, Masurekar A, Stern P, Whetton A, Saha V.

Blood. 2011 Jul 21;118(3):638-49. doi: 10.1182/blood-2010-09-307330. Epub 2011 May 23.

13.

Engraftment of low numbers of pediatric acute lymphoid and myeloid leukemias into NOD/SCID/IL2Rcγnull mice reflects individual leukemogenecity and highly correlates with clinical outcome.

Woiterski J, Ebinger M, Witte KE, Goecke B, Heininger V, Philippek M, Bonin M, Schrauder A, Röttgers S, Herr W, Lang P, Handgretinger R, Hartwig UF, André MC.

Int J Cancer. 2013 Oct 1;133(7):1547-56. doi: 10.1002/ijc.28170. Epub 2013 Apr 17.

14.

[Effect of glucocorticoid on the expression of Puma in acute lymphoblastic leukemia].

Xu B, Wang BJ, Li AM, Lock R.

Zhongguo Dang Dai Er Ke Za Zhi. 2006 Apr;8(2):151-4. Chinese.

PMID:
16613713
15.

Monitoring of engraftment and progression of acute lymphoblastic leukemia in individual NOD/SCID mice.

Nijmeijer BA, Mollevanger P, van Zelderen-Bhola SL, Kluin-Nelemans HC, Willemze R, Falkenburg JH.

Exp Hematol. 2001 Mar;29(3):322-9.

PMID:
11274760
16.

[Establishment of Human Acute B-Lymphoblastic Leukemia--NOD/SCID Xenotransplant Mouse Model].

Zhang X, Deng Y, Chen FL, Fang YJ, Zhang W, Yu L.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015 Jun;23(3):623-6. doi: 10.7534/j.issn.1009-2137.2015.03.004. Chinese.

PMID:
26117005
17.

Validation of a mouse xenograft model system for gene expression analysis of human acute lymphoblastic leukaemia.

Samuels AL, Peeva VK, Papa RA, Firth MJ, Francis RW, Beesley AH, Lock RB, Kees UR.

BMC Genomics. 2010 Apr 21;11:256. doi: 10.1186/1471-2164-11-256.

18.

[Establishment of human acute B-lymphoblastic leukemia NOD/SCID/IL2 receptor γ chain(null) neonatal mouse xenotransplant model].

Kong Y, Liu YR, Liu KY, Huang XJ, Ishikawa F, Harada M.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Jun;20(3):762-8. Chinese.

PMID:
22739198
19.

GSI-I (Z-LLNle-CHO) inhibits γ-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemia.

Meng X, Matlawska-Wasowska K, Girodon F, Mazel T, Willman CL, Atlas S, Chen IM, Harvey RC, Hunger SP, Ness SA, Winter SS, Wilson BS.

Leukemia. 2011 Jul;25(7):1135-46. doi: 10.1038/leu.2011.50. Epub 2011 Apr 15.

Supplemental Content

Support Center